Silo Pharma, Inc. (SILO) Stock

Silo Pharma, Inc. (SILO) is a Healthcare stock trading at $2.68 (as of 2026-08-21), with a market capitalization of $43.59M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Understand Silo Pharma, Inc.: how it makes money

Silo Pharma, Inc. is a healthcare company in the Pharmaceutical Products industry, reporting revenue from its pharmaceutical business.

With gross margin -15% and operating margin -8846%, the business is structurally loss-making at both the product (gross) level and the operating (expense) level.

Business quality (Unprofitable): Unprofitable, with gross margin -15% and operating margin -8846%.

Bull case

Gross losses are moderate: The company reports gross margin of -15%, indicating the first layer of profitability is negative, but the overall loss is not solely explained by gross economics.

Bear case

Operating losses are extreme: Operating margin is -8846%, showing that operating costs and expenses overwhelmingly overwhelm the business, even after gross results.

Valuation — source: SEC EDGAR (first-party)
Price	$2.68
Market Cap	$43.59M
Price / Book	7.67
Price / Sales	604.62

Profitability & Growth — source: SEC EDGAR
Revenue (TTM)	$72102.00
Net Margin	-5863.5%
Revenue Growth (YoY)	0.0%
EPS Growth (YoY)	-58.0%

Financial Health — source: SEC EDGAR
Altman Z-Score	13.15 (safe)

Valuation vs Sector & Industry
Sector P/E (Healthcare)	21.7
Industry P/E (Pharmaceutical Products)	17.0

Company
Sector	Healthcare
Industry	Pharmaceutical Products

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

Data as of 2026-08-21.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.